Medicines are used to treat breast cancer and also to help relieve side effects of treatment.
of medicines is typically used to treat breast cancer. The number of
cycles of treatment will depend on the medicines that are used and how the
medicines are given. Chemotherapy often uses several medicines together. Some of the most commonly used medicines
- Breast Cancer: Should I Have Chemotherapy for Early-Stage Breast Cancer?
side effects of chemotherapy depend mainly on the medicines you receive. As
with other types of treatment, side effects vary from person to person. Your doctor may also prescribe medicines to control and prevent nausea and vomiting.
Tamoxifen or an
aromatase inhibitor is recommended for
estrogen receptor-positive (ER+) breast cancer. These
medicines stop estrogen from fueling ER+ breast cancer.
- Tamoxifen is a medicine that blocks the effect of
estrogen on breast cancer cells and normal breast cells. But this medicine may also increase other
risks, such as for
blood clots in veins and
in the lungs.
- Aromatase inhibitors, such as letrozole
(Femara), anastrozole (Arimidex), and exemestane (Aromasin), are medicines that
stop estrogen production in postmenopausal women. Aromatase inhibitors are
used to treat early estrogen receptor-positive (ER+) breast cancer. They are
also used to treat metastatic or recurrent ER+ breast cancer. An aromatase
inhibitor can be used alone or after tamoxifen treatment.
Hormone-blocking treatments, such as tamoxifen or an
aromatase inhibitor, may cause fewer side effects than chemotherapy. If you are deciding
what type of medicine to use, weigh the benefits and risks of these medicines for your type of cancer.
Targeted therapies use medicines or substances that go directly to the cancer cells and don't harm normal cells. They include
monoclonal antibodies and tyrosine kinase inhibitors.
- Trastuzumab (Herceptin) is recommended after surgery and
HER-2/neu breast cancer. This medicine is a monoclonal antibody that targets the HER-2
protein. It helps chemotherapy work better.
- Lapatinib, a tyrosine kinase inhibitor, may be used to treat women who have HER-2+ cancer that has progressed even after they have taken trastuzumab.
- PARP inhibitor therapy is another kind of targeted therapy for triple-negative breast cancer (cancer cells that do not have estrogen or progesterone receptors or large amounts of HER2/neu).
E. Gregory Thompson, MD - Internal Medicine
Catherine D. Serio, PhD - Behavioral Health
June 18, 2012
©1995-2012, Healthwise, Incorporated, P.O. Box 1989, Boise, ID 83701.
ALL RIGHTS RESERVED
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.
For more information,
How this information was developed.